Currently holds positions in Adaptimmune Therapeutics PLC and WAVE Life Sciences Ltd
Position | Company | Period |
---|---|---|
Chief Financial Officer | Adaptimmune Therapeutics PLC | March 1, 2015 - |
Independent Director | WAVE Life Sciences Ltd | Feb. 1, 2017 - |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
30,080
-40.1%
0.6720,244 USD |
30,080 -40.1% | 0.67 | 20,244 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
17,257
-39.5%
0.8514,739 USD |
17,257 -39.5% | 0.85 | 14,739 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
11,945
-39.4%
0.849,994 USD |
11,945 -39.4% | 0.84 | 9,994 USD | |
2023-09-01 | 2023-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,403
-41.1%
0.781,874 USD |
2,403 -41.1% | 0.78 | 1,874 USD | |
2023-06-27 | 2023-06-27 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,333
-39.9%
0.922,146 USD |
2,333 -39.9% | 0.92 | 2,146 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
10,057
-43.0%
1.8618,686 USD |
10,057 -43.0% | 1.86 | 18,686 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
5,073
-43.3%
1.698,594 USD |
5,073 -43.3% | 1.69 | 8,594 USD | |
2022-09-01 | 2022-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,536
-43.3%
1.974,993 USD |
2,536 -43.3% | 1.97 | 4,993 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
11,096
-47.4%
3.1935,416 USD |
11,096 -47.4% | 3.19 | 35,416 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
3,046
-47.6%
3.5410,795 USD |
3,046 -47.6% | 3.54 | 10,795 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
14,362
-47.3%
3.5651,081 USD |
14,362 -47.3% | 3.56 | 51,081 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
5,532
-47.3%
4.0622,483 USD |
5,532 -47.3% | 4.06 | 22,483 USD | |
2021-06-28 | 2021-06-28 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,794
-47.7%
4.3712,210 USD |
2,794 -47.7% | 4.37 | 12,210 USD | |
2021-01-19 | 2021-01-19 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
9,879
-42.2%
5.6756,009 USD |
9,879 -42.2% | 5.67 | 56,009 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,707
-42.3%
6.1516,654 USD |
2,707 -42.3% | 6.15 | 16,654 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
4,967
-42.4%
5.3326,464 USD |
4,967 -42.4% | 5.33 | 26,464 USD | |
2020-09-02 | 2020-09-01 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,776
-47.4%
8.5123,637 USD |
2,776 -47.4% | 8.51 | 23,637 USD | |
2020-08-04 | 2020-08-03 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
2,788
-47.6%
9.2525,789 USD |
2,788 -47.6% | 9.25 | 25,789 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
3,236
-50.5%
5.1316,616 USD |
3,236 -50.5% | 5.13 | 16,616 USD | |
2020-01-07 | 2020-01-06 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
5,900
-50.4%
1.207,080 USD |
5,900 -50.4% | 1.20 | 7,080 USD | |
2019-01-16 | 2019-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
S Sale |
3,084
-48.2%
5.3716,559 USD |
3,084 -48.2% | 5.37 | 16,559 USD |